Amplified Sciences is a startup life science diagnostics company focused on accurately detecting and pre-empting the risks of debilitating diseases, including lethal cancers and organ loss with R&D operations in Purdue Research Park and research alliances in San Francisco and Boston. The company is developing a portfolio of diagnostic assays for early detection of disease. An ultra-sensitive molecular sensing technology licensed from Purdue operates with novel test-strips that combine with portable instrumentation to form a highly versatile clinical assay platform that can scale to point of care. The lead assay in development is at clinical testing stage and targets early detection of undiagnosed pancreatic cancers. The company closed a Seed round in 2020 which will enable technical and clinical validation of the PanCystPro product and position the company for entry into a commercializable lab developed test in 2023.
Pepperdine Graziadio Business School’s Most Fundable Companies of 2021